Tag: cardiac marker market share

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Cardiac Marker Market Revenue Outlook: What CAGR Lies Ahead Through 2030?

The cardiac marker market has shown swift growth in recent years. It is anticipated to increase from $12.38 billion in 2025 to $13.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. This historical expansion can be attributed to several factors including the escalating prevalence of cardiovascular diseases, the development of hospital laboratory infrastructure, the increased demand for emergency cardiac testing, the growing reliance on biomarker-based diagnostics, and advancements in assay sensitivity.

The cardiac marker market size is anticipated to undergo significant growth over the next few years. This market is set to reach $22.7 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This projected growth is driven by several factors, including a greater need for quick diagnostic test results, the increasing incorporation of cardiac diagnostics with digital platforms, the spread of point-of-care testing sites, the wider use of sophisticated biomarker panels, and a heightened emphasis on precision cardiology. Key developments anticipated during this period involve the increasing application of high-specificity cardiac marker panels, the growing uptake of automated immunoassay systems, a surging need for swift cardiac diagnoses, the broadening of multiparametric testing methods, and an intensified focus on supporting clinical decision-making.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=28911642&type=smp&name=Cardiac%20Marker%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Cardiac Marker Market Demand Drivers Opening New Revenue Streams

The increasing incidence of heart conditions is projected to drive expansion within the cardiac marker market in the foreseeable future. These heart-related ailments encompass various conditions impacting the heart’s structure or function, leading to diverse health issues. To diagnose and keep track of numerous cardiac problems such as heart attacks, angina, heart failure, and other cardiovascular disorders, cardiac markers are employed. Consequently, the need for diagnostic examinations using cardiac markers has grown. As an illustration, data from January 2024 released by the American Heart Association, a US-based non-profit group, indicated that the age-adjusted mortality rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, marking a 4.0% increase from 224.4 per 100,000 in 2023. Hence, the expanding occurrence of cardiac illnesses is set to stimulate the growth of the cardiac marker market.

Cardiac Marker Market Segment Outlook: Which Categories Are Growing Fastest?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Cardiac Marker Market Trends Powering Strategic Industry Growth

Leading companies in the cardiac marker market are concentrating on innovative offerings like high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers to boost their revenues. High-sensitivity troponin I (hs-cTnI) and NT-proBNP are two vital cardiac biomarkers employed for diagnosis, classification, and treatment. For example, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based firm specializing in the creation, manufacturing, and distribution of medical equipment and solutions, introduced troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has exceeded the minimum criteria for hs-cTn regarding sensitivity, accuracy, and reliability in detecting myocardial damage. These new offerings are designed to support enhanced treatment for cardiovascular illnesses by providing trustworthy solutions that improve patient outcomes both within and outside the scope of cardiovascular diseases.

Cardiac Marker Market Leading Players And Competitive Positioning

Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics

View The Full Cardiac Marker Market Report:

https://thebusinessresearchcompany.com/report/cardiac-marker-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Cardiac Marker Market Regional Split: Which Areas Are Fueling Growth?

North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The Cardiac Marker Market Between 2026 And 2030?

The cardiac marker market size has seen swift expansion in recent times. It is anticipated to increase from $12.38 billion in 2025 to $13.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. Historically, this growth has been fueled by the escalating prevalence of cardiovascular diseases, the enhancement of hospital laboratory infrastructure, the increased utilization of emergency cardiac testing, a rising reliance on biomarker-based diagnosis, and advancements in assay sensitivity.

The cardiac marker market is projected for substantial expansion over the coming years, with its size expected to reach $22.7 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.9%. This growth in the forecast period can be attributed to factors such as increasing demand for quicker diagnostic tests, the rising integration of cardiac diagnostics with digital platforms, the expansion of point-of-care testing facilities, a growing adoption of advanced biomarker panels, and an increasing focus on precision cardiology. Major trends anticipated during this period include the rising use of high-specificity cardiac marker panels, increased adoption of automated immunoassay systems, a growing need for rapid cardiac diagnosis, the expansion of multiparametric testing approaches, and an enhanced focus on clinical decision support.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

What Primary Factors Are Fueling The Expansion Of The Cardiac Marker Market?

An increasing incidence of cardiac diseases is anticipated to drive the expansion of the cardiac marker market moving forward. Cardiac diseases involve various conditions that impact the heart’s structure or function, resulting in a spectrum of health complications. Cardiac markers are utilized for diagnosing and tracking numerous cardiac conditions, including heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, the demand for these diagnostic tests, or cardiac markers, has grown. For example, in January 2024, as reported by the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, representing a 4.0% rise from 224.4 per 100,000 in 2023. Thus, the escalating prevalence of cardiac diseases will bolster the cardiac marker market’s growth.

Which Segment-Based Categories Are Covered In The Cardiac Marker Market?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Which Trends Are Contributing To Changes In The Cardiac Marker Market?

Leading companies active in the cardiac marker market are concentrating on innovative product development, such as high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers, to enhance their revenues. These two crucial cardiac biomarkers, high-sensitivity troponin I (hs-cTnI) and NT-proBNP, play a vital role in diagnosis, classification, and treatment. An illustration of this trend occurred in October 2023 when Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based company specializing in medical equipment and solutions, launched its troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay specifically exceeds the baseline criteria for hs-cTn in its ability to identify myocardial damage with high sensitivity, accuracy, and reliability. These recently introduced products are designed to support better management of cardiovascular illnesses by offering dependable solutions that lead to improved patient outcomes, both within and outside the scope of cardiovascular care.

Who Are The Leading Firms Participating In The Cardiac Marker Market?

Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics

Access The Complete Cardiac Marker Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

What Is The Largest Regional Market In The Cardiac Marker Market?

North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Cardiac Marker Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Browse Through More Reports Similar to the Global Cardiac Marker Market 2026, By The Business Research Company

Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report

Cardiac Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Wearable Heart Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Cardiac Marker Market During The Forecast Period?

The cardiac marker market has shown substantial expansion in recent years. It is anticipated to increase from $12.38 billion in 2025 to $13.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. Historically, this growth can be attributed to the rising burden of cardiovascular diseases, the expansion of hospital laboratory infrastructure, an increased use of emergency cardiac testing, a growing reliance on biomarker-based diagnosis, and improvements in assay sensitivity.

The cardiac marker market is projected to experience swift expansion over the coming years. This market is anticipated to reach $22.7 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.9%. This expansion during the projection period stems from a heightened need for quicker diagnostic test results, the growing incorporation of cardiac diagnostics into digital platforms, the proliferation of point-of-care testing locations, the increasing uptake of sophisticated biomarker panels, and a greater emphasis on precision cardiology. Key trends expected over the forecast horizon encompass a rise in the utilization of highly specific cardiac marker panels, the increasing embrace of automated immunoassay systems, a growing requirement for swift cardiac diagnoses, the broadening of multiparametric testing methodologies, and an elevated concentration on clinical decision support.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

What Major Factors Are Driving The Cardiac Marker Market Forward?

The increasing occurrence of cardiac diseases is anticipated to drive the expansion of the cardiac marker market in the foreseeable future. Cardiac diseases encompass a variety of conditions that affect the heart’s structure or operation, resulting in diverse medical problems. Cardiac markers are employed for diagnosing and monitoring numerous cardiac conditions, such as heart attacks, angina, heart failure, and other cardiovascular diseases. Consequently, the demand for diagnostic tests, particularly cardiac markers, has risen. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the escalating prevalence of cardiac diseases will fuel the cardiac marker market’s growth.

How Are Different Segments Classified In The Cardiac Marker Market Segment Analysis?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Which Trends Are Impacting The Progress Of The Cardiac Marker Market?

Leading companies in the cardiac marker market are prioritizing innovative products like high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers to increase their market revenues. High-sensitivity troponin I (hs-cTnI) and NT-proBNP are vital cardiac biomarkers utilized for diagnosis, classification, and treatment. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based firm specializing in the development, manufacturing, and distribution of medical equipment and solutions, introduced troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has surpassed the minimum requirements for hs-cTn in terms of its sensitivity, accuracy, and reliability for identifying myocardial damage. These new products aim to support improved treatment for cardiovascular illnesses by delivering dependable solutions that enhance patient outcomes both within and outside the scope of cardiovascular diseases.

Who Are The Companies Driving Activity In The Cardiac Marker Market?

Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics

Get The Full Cardiac Marker Market Report:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

Which Region Has The Greatest Market Share In The Cardiac Marker Market?

North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cardiac Marker Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Browse Through More Reports Similar to the Global Cardiac Marker Market 2026, By The Business Research Company

Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report

Cardiac Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Wearable Heart Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Cardiac Marker Market Across 2026–2030?

The cardiac marker market size has experienced rapid expansion in recent years. This market is projected to expand from $12.38 billion in 2025 to $13.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 12.7%. Historically, this growth has been fueled by factors such as the rising incidence of cardiovascular diseases, the broadening of hospital laboratory infrastructure, an increased demand for emergency cardiac testing, a greater dependence on biomarker-based diagnosis, and advancements in assay sensitivity.

The cardiac marker market is projected for significant expansion in the coming years. By 2030, this market is anticipated to reach $22.7 billion, demonstrating a compound annual growth rate (CAGR) of 12.9%. This growth during the forecast period is propelled by factors such as a greater need for quicker diagnostic test results, enhanced integration of cardiac diagnostics with digital systems, the proliferation of point-of-care testing sites, wider acceptance of sophisticated biomarker panels, and an increased emphasis on precision cardiology. Key trends anticipated during the same period encompass the heightened utilization of high-specificity cardiac marker panels, increased deployment of automated immunoassay systems, a growing desire for swift cardiac diagnosis, the broadening of multiparametric testing methodologies, and a stronger focus on clinical decision support mechanisms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

What Primary Drivers Are Shaping The Development Of The Cardiac Marker Market?

The increasing occurrence of cardiac conditions is anticipated to drive expansion in the cardiac marker market moving ahead. These conditions encompass various ailments impacting the heart’s structure or function, leading to diverse health issues. Cardiac markers play a crucial role in the diagnosis and oversight of numerous heart-related ailments, such as heart attacks, angina, heart failure, and other cardiovascular problems. Consequently, there has been an uptick in the need for diagnostic tests utilizing cardiac markers. For instance, in January 2024, the American Heart Association, a US-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, which was a 4.0% rise from 224.4 per 100,000 in 2023. This escalating incidence of cardiac diseases is therefore poised to further stimulate the growth of the cardiac marker market.

What Segmentation Levels Are Considered In The Cardiac Marker Market?

The cardiac marker market covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

What Trends Are Projected To Affect The Cardiac Marker Market?

Leading companies within the cardiac marker market are concentrating on the development of innovative products, such as high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers, to enhance their market revenues. High-sensitivity troponin I (hs-cTnI) and NT-proBNP are crucial cardiac biomarkers employed in the diagnosis, classification, and treatment of conditions. Illustratively, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based company known for medical equipment and solutions, unveiled its troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has exceeded the minimal requirements for hs-cTn in terms of its sensitivity, accuracy, and reliability for detecting myocardial damage. These new offerings are designed to facilitate improved treatment for cardiovascular illnesses by delivering reliable solutions that lead to better patient outcomes both within and beyond the scope of cardiovascular diseases.

Which Leading Firms Are Contributing To The Growth Of The Cardiac Marker Market?

Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics

Read the full cardiac marker market report here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

How Does The Cardiac Marker Market Perform Across Major Global Regions?

North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cardiac Marker Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Browse Through More Reports Similar to the Global Cardiac Marker Market 2026, By The Business Research Company

Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report

Cardiac Arrhythmia Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report

Wearable Heart Monitoring Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the software as a service (saas) testing tool market from 2026–2035 with trusted insights from The Business Research Company

How much is the Cardiac Marker Market valued at in 2026, and what valuation is forecast for 2030?_x000D_

The cardiac marker market has experienced rapid expansion in its valuation recently. It is projected to escalate from $12.38 billion in 2025 to $13.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.7%. This historical growth can be ascribed to factors such as the increasing incidence of cardiovascular diseases, the enlargement of hospital laboratory infrastructure, a surge in the utilization of emergency cardiac testing, a heightened dependence on biomarker-based diagnosis, and enhancements in assay sensitivity._x000D_

_x000D_

The cardiac marker market is projected for significant expansion in the coming years, reaching a valuation of $22.7 billion by 2030, driven by a compound annual growth rate (CAGR) of 12.9%. This anticipated growth throughout the forecast period stems from factors such as a heightened demand for quicker diagnostic test results, the escalating integration of cardiac diagnostic methods with digital platforms, the broader availability of point-of-care testing facilities, the increasing use of sophisticated biomarker panels, and a greater emphasis on precision cardiology. Key trends anticipated during this period encompass the expanded application of high-specificity cardiac marker panels, a surge in the adoption of automated immunoassay systems, an escalating need for swift cardiac diagnoses, the proliferation of multiparametric testing methodologies, and a stronger emphasis on supporting clinical decision-making._x000D_

_x000D_

#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp_x000D_

_x000D_

What Drivers Are Influencing The Growth Of The Cardiac Marker Market?_x000D_

The escalating occurrence of cardiac conditions is projected to boost the expansion of the cardiac marker market in the foreseeable future. These diseases encompass various ailments impacting the heart’s structure or function, leading to diverse health complications. Cardiac markers serve as diagnostic and monitoring tools for numerous heart-related issues, such as heart attacks, angina, heart failure, and other forms of cardiovascular illness. Consequently, the need for diagnostic tests utilizing cardiac markers has risen. For instance, in January 2024, the American Heart Association, a US-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, showing a 4.0% increase from 224.4 per 100,000 in 2023. This indicates that the increasing occurrence of cardiac ailments will significantly contribute to the cardiac marker market’s expansion._x000D_

_x000D_

What Segments Are Included Within The Cardiac Marker Market?_x000D_

The cardiac marker market covered in this report is segmented – _x000D_

_x000D_

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers_x000D_

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA_x000D_

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications_x000D_

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions_x000D_

_x000D_

Subsegments:_x000D_

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits_x000D_

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels_x000D_

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels_x000D_

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels_x000D_

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)_x000D_

_x000D_

_x000D_

_x000D_

Which Innovation Trends Are Advancing Developments Within The Cardiac Marker Market?_x000D_

Major companies operating in the cardiac marker market are emphasizing innovative products like high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers to increase their market revenues. High-sensitivity troponin I (hs-cTnI) and NT-proBNP are two crucial cardiac biomarkers utilized for diagnosis, classification, and treatment. For instance, in October 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based company specializing in medical equipment and solutions development, manufacturing, and distribution, launched troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The hs-cTn assay has surpassed the minimal requirements for hs-cTn concerning sensitivity, accuracy, and reliability in detecting myocardial damage. These new products are designed to support enhanced treatment for cardiovascular illnesses by offering dependable solutions that improve patient outcomes both within and beyond cardiovascular disease contexts._x000D_

_x000D_

Who Are The Primary Competitors In The Global Cardiac Marker Market?_x000D_

Major companies operating in the cardiac marker market are Abbott Laboratories, F Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc, bioMérieux SA, Bio-Rad Laboratories Inc, Beckman Coulter Inc, QuidelOrtho Corporation, Randox Laboratories Ltd, DiaSorin SpA, Tosoh Corporation, PerkinElmer Inc, Sysmex Corporation, Mindray Bio-Medical Electronics Co Ltd, Lepu Medical Technology Beijing Co Ltd, Trinity Biotech plc, Fujirebio Holdings Inc, Euroimmun AG, Abcam plc, Creative Diagnostics _x000D_

_x000D_

#Access The Complete Report For Deeper Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report_x000D_

_x000D_

Which Global Regions Are Shaping The Competitive Landscape Of The Cardiac Marker Market?_x000D_

North America was the largest region in the cardiac marker market in 2025. The regions covered in the cardiac marker market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request Your Customized Cardiac Marker Market Research Report for Competitive Advantage:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Cardiac Marker Market 2026, By The Business Research Company#_x000D_

_x000D_

Arrhythmia Monitoring Devices Global Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report_x000D_

_x000D_

Cardiac Arrhythmia Monitoring Devices Global Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/cardiac-arrhythmia-monitoring-devices-global-market-report_x000D_

_x000D_

Wearable Heart Monitoring Devices Global Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/wearable-heart-monitoring-devices-global-market-report_x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

Uncover key drivers, emerging technologies, and competitive movements shaping the cardiac marker market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Cardiac Marker Market?

The cardiac marker market has demonstrated significant growth in recent years. It is anticipated to expand from $11.26 billion in 2024 to $12.38 billion in 2025, progressing at a compound annual growth rate (CAGR) of 9.9%. The expansion observed historically can be attributed to several factors including an elevated incidence of cardiovascular diseases, an aging demographic coupled with cardiovascular risk, public awareness initiatives and health screenings, the incorporation of biomarkers into clinical practice, and rigorous regulatory standards and guidelines.

The cardiac marker market size is anticipated to undergo significant expansion in the coming years. This market is projected to grow to $20.05 billion by 2029, achieving a compound annual growth rate (CAGR) of 12.8%. The expansion during the forecast period can be linked to factors such as the rising burden of lifestyle-related diseases, remote monitoring and telemedicine, personalized medicine and precision diagnostics, point-of-care testing (poct) adoption, and collaborations and partnerships in healthcare. Noteworthy trends for the forecast period encompass biomarker discovery and validation, personalized medicine approaches, technological advancements in assay platforms, integration of high-sensitivity troponin tests, and an increase in cardiovascular disease prevalence.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

Which Growth Drivers Are Propelling The Cardiac Marker Market?

The increasing occurrence of heart conditions is anticipated to drive the expansion of the cardiac marker market in the future. Heart diseases encompass various conditions impacting the heart’s structure or function, leading to diverse health issues. Cardiac markers serve to diagnose and track numerous heart-related ailments such as heart attacks, angina, heart failure, and other cardiovascular disorders. Consequently, there has been a rise in the need for diagnostic tests, specifically cardiac markers. For example, the British Heart Foundation, a UK-based cardiovascular research charity, reported an additional 30,000 deaths from coronary heart disease in England between the pandemic’s onset and August 2022. By the close of August 2022, a record total of 346,000 individuals were awaiting cardiac treatment. Hence, the growing incidence of cardiac diseases will stimulate the growth of the cardiac marker market.

Which Segmentation Factors Are Most Significant In The Cardiac Marker Market Analysis?

The cardiac markermarket covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

What New Opportunities Are Emerging From Trends In The Cardiac Marker Market?

Product innovation is a key trend gaining significant popularity within the cardiac marker market. Major market players are concentrating on developing innovative solutions to bolster their standing in the sector. For instance, in September 2022, MiRxes, a biotechnology company headquartered in Singapore, validated a microRNA-based diagnostic test designed for the early detection and diagnosis of illnesses. Once commercialized, this test is expected to expand MiRxes’ portfolio of blood tests for cancer, providing a comprehensive array of early detection choices to mitigate the increasing clinical and socioeconomic burden of severe conditions, including cancer and cardio-pulmonary disorders.

Who Are The Most Influential Companies In The Cardiac Marker Market?

Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

Which Region Holds The Largest Share In The Cardiac Marker Market Today?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Browse Through More Reports Similar to the Global Cardiac Marker Market 2025, By The Business Research Company

Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Cardiac Marker Market Be Worth By 2029?

In recent times, there has been a significant expansion in the size of the cardiac marker market. The predicted growth is from $11.26 billion in 2024 to $12.38 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 9.9%. Several factors contribute to this growth observed in the historical period, including an increased occurrence of cardiovascular diseases, an aging population coupled with cardiovascular risks, heightened awareness and health screening programs, the incorporation of biomarkers in clinical procedures, and strict regulatory norms and guidelines.

The cardiac marker market is anticipated to witness a significant surge in its size in the coming years. A compound annual growth rate (CAGR) of 12.8% is projected, increasing the market size to $20.05 billion by 2029. Factors contributing to this growth during the forecast period include an increased prevalence of lifestyle-related diseases, advancements in remote monitoring and telemedicine, the development of personalized medicine and precision diagnostics, adoption of point-of-care testing (poct), as well as partnerships and collaborations in the healthcare sector. Future trends that will mark the forecast period range from biomarker discovery and validation, personalized medicine techniques, advancements in assay platform technologies, the incorporation of high-sensitivity troponin tests, and a rise in cardiovascular disease occurrence.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

What Market Forces Are Contributing To The Growth Of The Cardiac Marker Market?

The escalating occurrence of heart-related ailments is anticipated to drive the expansion of the cardiac marker market in the future. Cardiac diseases consist of various conditions that impact the heart’s structure or function and result in numerous health issues. Cardiac markers play a crucial role in diagnosing and supervising a variety of heart disorders, such as heart attacks, angina, heart failure, and other cardiovascular diseases. As a result, there has been an increased demand for diagnostic tests or cardiac markers. For example, the British Heart Foundation, a UK-based cardiovascular research charity, stated that England had witnessed an increase in coronary heart disease fatalities by 30,000 from the onset of the pandemic until August 2022. Additionally, an unprecedented number of 346,000 individuals were on a cardiac waiting list by the conclusion of August 2022. Therefore, the escalating prevalence of heart-related diseases is expected to spur the growth of the cardiac marker market.

Which Segments Define The Structure Of The Cardiac Marker Market?

The cardiac markermarket covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

What Strategic Shifts And Innovations Are Influencing The Cardiac Marker Market?

The cardiac marker market is increasingly influenced by a major trend of product innovation. Leading players in the market are concentrating on developing innovative solutions in order to fortify their market standing. An exemplar of this is when MiRxes, a biotech firm based in Singapore, approved a microRNA-based diagnostic assessment for the early recognition and diagnostic process of diseases in September 2022. Once this test hits the market, it will complement MiRxes’ existing suite of blood examinations for cancer, providing a broad spectrum of early detection strategies. This move is aimed at mitigating the enlarging clinical and socioeconomic impact of severe diseases, encompassing cancer and cardio-pulmonary conditions.

Which Firms Are Making The Biggest Impact In The Cardiac Marker Market?

Major companies operating in the cardiac marker market include Abbott Laboratories Inc., Siemens AG, Danaher Corporation, BioMérieux SA, F. Hoffmann-La Roche AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Guangzhou Wondifo Biotech Co. Ltd., Creative Diagnostics, PerkinElmer Inc., Tosoh Corporation, Quidel Corporation, Randox Laboratories Ltd., Getinge Group, LSI Medience Corporation, Ortho Clinical Diagnostics, DiaSorin, 3M Company, Atom Medical Corporation, Bionet America Inc., Bistos Inc., CareFusion Corporation, Clinical Innovations LLC, Abcam plc, General Electric Company

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

Which Region Is Forecasted To Lead The Cardiac Marker Market In The Coming Years?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Browse Through More Reports Similar to the Global Cardiac Marker Market 2025, By The Business Research Company

Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pacemakers-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cardiac Marker Market Growth Performance Trended Historically, And What Lies Ahead?

There has been significant growth in the size of the cardiac marker market in the past few years. The market, which was worth $11.26 billion in 2024, is projected to expand to $12.38 billion in 2025, implying a compound annual growth rate (CAGR) of 9.9%. The growth throughout the historic period can be credited to factors such as the rising occurrence of cardiovascular diseases, an aging populace and cardiovascular risk, awareness initiatives and health checkups, the incorporation of biomarkers in clinical procedures, as well as stringent regulatory norms and guidelines.

Expected to experience rapid expansion in the near future, the cardiac marker market size is projected to reach $20.05 billion by 2029, with a compound annual growth rate (CAGR) of 12.8%. This growth during the forecast period is due to factors such as an increasing prevalence of lifestyle-related diseases, the rise of remote monitoring and telemedicine, the growth of personalized medicine and precision diagnostics, and the popularity of point-of-care testing (POCT) adoption, as well as healthcare collaborations and partnerships. The forecast period will also see significant trends such as biomarker discovery and validation, personalized medicine strategies, advancements in assay platform technologies, the implementation of highly sensitive troponin tests, and a surge in cardiovascular disease incidents.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Cardiac Marker Market?

An upsurge in heart disease cases is anticipated to stimulate the cardiac marker industry’s expansion. Heart conditions, which can cause a variety of health issues, encompass a collection of disorders that affect the heart’s structure or functionality. Cardiac markers enable the diagnosis and monitoring of several heart ailments like heart attacks, angina, heart failure, and other cardiovascular diseases, intensifying the need for these diagnostic tests. For example, the British Heart Foundation, a cardiovascular research charity in England, reported 30,000 additional fatalities from coronary heart disease since the onset of the pandemic until August 2022. At the close of August 2022, an unprecedented 346,000 individuals were on a cardiac waiting list. Consequently, the escalation in heart disease prevalence is set to accelerate the expansion of the cardiac marker market.

Which Key Market Segments Comprise the Cardiac Marker Market and Drive Its Revenue Growth?

The cardiac markermarket covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Which Areas Are Leading Regions in the Cardiac Marker Market Expansion Across the Globe?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theCardiac Marker Market Over the Coming Years?

The striving for product innovation is becoming a central trend in the cardiac marker market. Companies dominating the market are actively pursuing innovative solutions to establish their authority in the industry. For example, Singaporean biotech firm MiRxes confirmed a microRNA-based diagnostic examination for early illness detection and diagnosis in September 2022. Once it becomes commercial, this test will improve MiRxes’ range of blood tests for cancer, presenting a comprehensive set of early detection methods to decrease the escalating clinical and economic impact of severe ailments like cancer and cardio-pulmonary diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

How Is the Cardiac Marker Market Conceptually Defined?

Cardiac markers are biomolecules that are released into the bloodstream when there is damage or stress to the heart muscle. It is used to diagnose and monitor a variety of cardiac diseases, including heart attacks, angina, and heart failure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10053

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cardiac Marker Market Growth Performance Trended Historically, And What Lies Ahead?

There has been significant growth in the size of the cardiac marker market in the past few years. The market, which was worth $11.26 billion in 2024, is projected to expand to $12.38 billion in 2025, implying a compound annual growth rate (CAGR) of 9.9%. The growth throughout the historic period can be credited to factors such as the rising occurrence of cardiovascular diseases, an aging populace and cardiovascular risk, awareness initiatives and health checkups, the incorporation of biomarkers in clinical procedures, as well as stringent regulatory norms and guidelines.

Expected to experience rapid expansion in the near future, the cardiac marker market size is projected to reach $20.05 billion by 2029, with a compound annual growth rate (CAGR) of 12.8%. This growth during the forecast period is due to factors such as an increasing prevalence of lifestyle-related diseases, the rise of remote monitoring and telemedicine, the growth of personalized medicine and precision diagnostics, and the popularity of point-of-care testing (POCT) adoption, as well as healthcare collaborations and partnerships. The forecast period will also see significant trends such as biomarker discovery and validation, personalized medicine strategies, advancements in assay platform technologies, the implementation of highly sensitive troponin tests, and a surge in cardiovascular disease incidents.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10053&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Cardiac Marker Market?

An upsurge in heart disease cases is anticipated to stimulate the cardiac marker industry’s expansion. Heart conditions, which can cause a variety of health issues, encompass a collection of disorders that affect the heart’s structure or functionality. Cardiac markers enable the diagnosis and monitoring of several heart ailments like heart attacks, angina, heart failure, and other cardiovascular diseases, intensifying the need for these diagnostic tests. For example, the British Heart Foundation, a cardiovascular research charity in England, reported 30,000 additional fatalities from coronary heart disease since the onset of the pandemic until August 2022. At the close of August 2022, an unprecedented 346,000 individuals were on a cardiac waiting list. Consequently, the escalation in heart disease prevalence is set to accelerate the expansion of the cardiac marker market.

Which Key Market Segments Comprise the Cardiac Marker Market and Drive Its Revenue Growth?

The cardiac markermarket covered in this report is segmented –

1) By Biomarker: Troponin, Creatine Kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, Other Biomarkers

2) By Product: Reagent, Instrument, Chemiluminescence, Immunofluorescence, Immunochromatography, ELISA

3) By Indication: Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Other Indications

4) By End User: Laboratory Testing Facilities, Hospital Labs, Reference Labs, Contract Testing Labs, Point-Of-Care Testing Facilities, Academic Institutions

Subsegments:

1) By Troponin: Troponin I, Troponin T, Troponin Diagnostic Kits

2) By Creatine Kinase-MB (CK-MB): CK-MB Test Kits, CK-MB Diagnostic Panels

3) By B-Type Natriuretic Peptide (BNP): BNP Test Kits, NT-ProBNP Test Kits, BNP Diagnostic Panels

4) By Myoglobin: Myoglobin Test Kits, Myoglobin Diagnostic Panels

5) By Other Biomarkers: Ischemia Modified Albumin (IMA), Heart Fatty Acid Binding Protein (HFABP), C-Reactive Protein (CRP)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=10053&type=smp

Which Areas Are Leading Regions in the Cardiac Marker Market Expansion Across the Globe?

North America was the largest region in the cardiac marker market in 2024. The regions covered in the cardiac marker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Key Market Trends in theCardiac Marker Market Over the Coming Years?

The striving for product innovation is becoming a central trend in the cardiac marker market. Companies dominating the market are actively pursuing innovative solutions to establish their authority in the industry. For example, Singaporean biotech firm MiRxes confirmed a microRNA-based diagnostic examination for early illness detection and diagnosis in September 2022. Once it becomes commercial, this test will improve MiRxes’ range of blood tests for cancer, presenting a comprehensive set of early detection methods to decrease the escalating clinical and economic impact of severe ailments like cancer and cardio-pulmonary diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cardiac-marker-global-market-report

How Is the Cardiac Marker Market Conceptually Defined?

Cardiac markers are biomolecules that are released into the bloodstream when there is damage or stress to the heart muscle. It is used to diagnose and monitor a variety of cardiac diseases, including heart attacks, angina, and heart failure.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10053

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model